Does Vyvanse Cause Low Vitamin D Levels?
No, Vyvanse (lisdexamfetamine) does not cause vitamin D deficiency. There is no established causal relationship between Vyvanse use and low vitamin D levels based on available evidence.
Evidence Review
FDA Drug Label Findings
The official FDA prescribing information for Vyvanse does not list vitamin D deficiency or any vitamin-related adverse effects among its documented side effects 1. The comprehensive drug label details numerous potential adverse reactions including:
- Cardiovascular effects (increased blood pressure and heart rate) 1
- Psychiatric symptoms (psychosis, mania, behavioral changes) 1
- Growth suppression in pediatric patients 1
- Peripheral vasculopathy 1
- Gastrointestinal effects 1
Notably absent from this extensive list is any mention of vitamin D metabolism interference or deficiency 1.
Pharmacological Mechanism
Vyvanse is a prodrug that is hydrolyzed to d-amphetamine in the blood, which then acts primarily on dopamine and noradrenaline transporters in the central nervous system 2. The mechanism of action involves:
- Competitive inhibition of dopamine transporter (DAT) and noradrenaline transporter (NAT) 2
- Promotion of neurotransmitter release by acting on vesicular monoamine transporter 2
This pharmacological profile does not involve pathways that would interfere with vitamin D synthesis, absorption, or metabolism 2.
Known Causes of Vitamin D Deficiency
According to current guidelines, established risk factors for vitamin D deficiency include 3:
- Decreased dietary vitamin D intake 3
- Malabsorption conditions (inflammatory bowel disease, short gut syndrome, Roux-en-Y gastric bypass) 4
- Limited sun exposure (high latitude, winter season, clothing coverage) 3
- Darker skin pigmentation 3
- Obesity (due to sequestration in adipose tissue) 3
- Chronic kidney disease (increased 24-hydroxylase activity) 4
- Nephrotic syndrome (urinary loss of vitamin D-binding protein) 4
- Certain medications that affect vitamin D hydroxylases 4
Amphetamines and CNS stimulants are not listed among medications known to cause vitamin D deficiency 4, 5.
Clinical Implications
If Vitamin D Deficiency is Present
If a patient on Vyvanse has documented low vitamin D levels, investigate the actual causes 3:
- Assess dietary intake and sun exposure patterns 3
- Evaluate for malabsorption disorders 4
- Review all medications for known vitamin D-depleting drugs 4, 5
- Consider obesity and skin pigmentation as contributing factors 3
Treatment Approach
For patients requiring both Vyvanse and vitamin D supplementation 6:
- Use cholecalciferol (vitamin D3) 800-1000 IU daily for prevention/correction of deficiency 6
- Calcifediol 10 µg/day is a safe alternative 6
- Avoid doses exceeding 4000 IU/day long-term due to potential harm 7
- Target serum 25(OH)D levels of 30-50 ng/mL (75-125 nmol/L) 6
Important Caveats
The appetite-suppressing effects of Vyvanse could theoretically lead to decreased dietary vitamin D intake if nutritional intake becomes inadequate 1, 2. However, this would be an indirect effect related to reduced food consumption, not a direct drug-vitamin interaction. Monitor nutritional status in patients experiencing significant appetite suppression 1.
Weight loss associated with Vyvanse use does not increase vitamin D deficiency risk—in fact, obesity is associated with lower vitamin D levels, so weight normalization might improve vitamin D status 3.